Skip to main content

AlphaCentric Advisors LLC

SEC CIK
0001913464
Latest filing
Jul 24, 2026

ASND holding history

Ascendis Pharma A/S in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ASND overviewAll 13F holders of ASNDFull Q2 2026 holdings

Shares (Q2 2026)
4,585
Value
$1.22M
% of portfolio
1.0%
Quarters held
3
Since Q4 2025
Holdings of ASND by AlphaCentric Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,585$1.22M1.0%+59+1.3%AddedHolders
Q1 20264,526$1.04M1.0%+1,288+39.8%AddedHolders
Q4 20253,238$690.5K0.7%–No prior filingHolders